Eli Lilly and Company (0Q1G)
LSE
Real-time Data
07:00 AM
Day's Range
1,020.0052 wk Range
460.00Profile - 0Q1G - Eli Lilly and Company
Profile
Mic Code
XLON
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
50K
Eli Lilly and Company is a global pharmaceutical company that discovers, develops, manufactures, and markets medicines for human health. The company focuses on major therapeutic areas including cardiometabolic health, oncology, immunology, neuroscience, and rare diseases, with a portfolio that spans treatments for diabetes, obesity, cancer, autoimmune conditions, and neurological disorders. Eli Lilly and Company also operates in animal health-related products in some markets, supporting a broader healthcare presence. Its business is centered on prescription medicines and biologic therapies, combining research, clinical development, and large-scale manufacturing to serve patients, healthcare providers, and health systems worldwide. Headquartered in Indianapolis, Indiana, Eli Lilly and Company is widely recognized for its role in advancing innovative treatments and maintaining a strong position in the global pharmaceutical market.
Profile Details
Type
Common Stock
Ceo
Mr. David A. Ricks
Address
Lilly Corporate Center
City
Indianapolis
State
IN
Zip
46285
Country
United States
Phone
317 276 2000
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
